TX HB 2750
died on adjournmentRelating to use of a pharmacy benefit manager in which a health benefit plan issuer has a financial interest.
Texas · 89th Legislature (2025 Regular Session) · lower
Quick answers
Did TX HB 2750 pass?
No. TX HB 2750 died when the 89th Legislature (2025 Regular Session) adjourned without final action on it. Bills that die this way are sometimes reintroduced in a later session. Latest recorded action (2025-04-09): Left pending in committee
What is TX HB 2750 about?
TX HB 2750 is a bill in the 89th Legislature (2025 Regular Session) titled “Relating to use of a pharmacy benefit manager in which a health benefit plan issuer has a financial interest.”.
Who sponsors TX HB 2750?
Harris is the primary sponsor of TX HB 2750.
- Introduced
- 2025-03-18
- Latest action
- 2025-04-09 — Left pending in committee
- Bill type
- bill
- Last updated
- —
Subjects
Sponsors
- Harrisprimary
Committees
Not provided by source.
Action timeline
2025-02-12
Filed
filing
2025-03-18
Read first time
introduction,reading-1
2025-03-18
Referred to Insurance
referral-committee
2025-04-09
Considered in public hearing
2025-04-09
Committee substitute considered in committee
substitution
2025-04-09
Testimony taken/registration(s) recorded in committee
2025-04-09
Left pending in committee
Versions
Documents
Votes
Not provided by source.
Related bills
No related bills recorded for this bill.
Official source
Attribution
Data from openstates_bulk_csv, retrieved 2026-07-24T05:33:51.767464Z
Inspect retained evidence for changes recorded after evidence tracking began:
Session-wide evidence can include changes to other bills:
Use this data
Every field on this page is available from the free public API — no key or licence required. Fetch this bill as JSON: GET /api/v1/bills?jurisdiction=TX&identifier=HB 2750. See the API docs or the MCP server for AI assistants.
Known limitations
- Sponsor party and chamber affiliation are not yet captured by this API.
- Committee referrals are not yet captured.
See the methodology page for data sources and limitations.